194 related articles for article (PubMed ID: 22253523)
1. ¹⁸F-fluoro-2-deoxyglucose uptake on PET CT and glucose transporter 1 expression in colorectal adenocarcinoma.
Hong R; Lim SC
World J Gastroenterol; 2012 Jan; 18(2):168-74. PubMed ID: 22253523
[TBL] [Abstract][Full Text] [Related]
2. Correlation between glucose transporter-1 expression and 18F-fluoro-2-deoxyglucose uptake on positron emission tomography in lung cancer.
Usuda K; Sagawa M; Aikawa H; Ueno M; Tanaka M; Machida Y; Zhao XT; Ueda Y; Higashi K; Sakuma T
Gen Thorac Cardiovasc Surg; 2010 Aug; 58(8):405-10. PubMed ID: 20703861
[TBL] [Abstract][Full Text] [Related]
3. Association between [18F]-fluoro-2-deoxyglucose uptake and expressions of hypoxia-induced factor 1α and glucose transporter 1 in non-small cell lung cancer.
Furukawa T; Miyata Y; Kushitani K; Mimae T; Tsutani Y; Takeshima Y; Okada M
Jpn J Clin Oncol; 2015 Dec; 45(12):1154-61. PubMed ID: 26386467
[TBL] [Abstract][Full Text] [Related]
4. GLUT1 expression in high-risk prostate cancer: correlation with
Meziou S; Ringuette Goulet C; Hovington H; Lefebvre V; Lavallée É; Bergeron M; Brisson H; Champagne A; Neveu B; Lacombe D; Beauregard JM; Buteau FA; Riopel J; Pouliot F
Prostate Cancer Prostatic Dis; 2020 Sep; 23(3):441-448. PubMed ID: 31932660
[TBL] [Abstract][Full Text] [Related]
5. Correlations between SUVmax and expression of GLUT1 and growth factors inducing lymphangiogenesis.
Tian M; Yu L; Zhang Y; Gao X
Acad Radiol; 2012 Apr; 19(4):420-6. PubMed ID: 22444673
[TBL] [Abstract][Full Text] [Related]
6. Hypoxia-induced modulation of glucose transporter expression impacts
Xia H; Chen J; Gao H; Kong SN; Deivasigamani A; Shi M; Xie T; Hui KM
Eur J Nucl Med Mol Imaging; 2020 Apr; 47(4):787-797. PubMed ID: 31832727
[TBL] [Abstract][Full Text] [Related]
7. Analysis of the roles of glucose transporter 1 and hexokinase 2 in the metabolism of glucose by extrahepatic bile duct cancer cells.
Yoon SO; Jeon TJ; Park JS; Ryu YH; Lee JH; Yoo JS; Kim JK; Yoon DS; Oh EJ
Clin Nucl Med; 2015 Mar; 40(3):e178-82. PubMed ID: 25608150
[TBL] [Abstract][Full Text] [Related]
8. Correlation of GLUT-1 overexpression, tumor size, and depth of invasion with 18F-2-fluoro-2-deoxy-D-glucose uptake by positron emission tomography in colorectal cancer.
Gu J; Yamamoto H; Fukunaga H; Danno K; Takemasa I; Ikeda M; Tatsumi M; Sekimoto M; Hatazawa J; Nishimura T; Monden M
Dig Dis Sci; 2006 Dec; 51(12):2198-205. PubMed ID: 17080242
[TBL] [Abstract][Full Text] [Related]
9. Clinical Significance of
Betsunoh H; Sakamoto S; Kaji Y; Nukui A; Kobayashi M; Yashi M; Hayashi K; Anzai N; Kamai T
Anticancer Res; 2021 Oct; 41(10):5179-5188. PubMed ID: 34593470
[TBL] [Abstract][Full Text] [Related]
10. Maximum standardized uptake value on 18F-fluoro-2-deoxy-glucose positron emission tomography/computed tomography and glucose transporter-1 expression correlates with survival in invasive ductal carcinoma of the pancreas.
Kitasato Y; Yasunaga M; Okuda K; Kinoshita H; Tanaka H; Okabe Y; Kawahara A; Kage M; Kaida H; Ishibashi M
Pancreas; 2014 Oct; 43(7):1060-5. PubMed ID: 25121413
[TBL] [Abstract][Full Text] [Related]
11. Glucose transporter 1 expression, tumor proliferation, and iodine/glucose uptake in thyroid cancer with emphasis on poorly differentiated thyroid carcinoma.
Grabellus F; Nagarajah J; Bockisch A; Schmid KW; Sheu SY
Clin Nucl Med; 2012 Feb; 37(2):121-7. PubMed ID: 22228332
[TBL] [Abstract][Full Text] [Related]
12. [Correlation between SUV of (18)F-FDG PET-CT and the expression of GLUT1, MVD and Ki67 in non-small cell lung cancer].
Duan Y; Yu LJ; Lu PO; Wang WZ
Zhonghua Zhong Liu Za Zhi; 2008 Oct; 30(10):764-7. PubMed ID: 19173807
[TBL] [Abstract][Full Text] [Related]
13. Hyperaccumulation of (18)F-FDG in order to differentiate solid pseudopapillary tumors from adenocarcinomas and from neuroendocrine pancreatic tumors and review of the literature.
Guan ZW; Xu BX; Wang RM; Sun L; Tian JH
Hell J Nucl Med; 2013; 16(2):97-102. PubMed ID: 23687644
[TBL] [Abstract][Full Text] [Related]
14. [
de Koster EJ; van Engen-van Grunsven ACH; Bussink J; Frielink C; de Geus-Oei LF; Kusters B; Peters H; Oyen WJG; Vriens D;
Mol Imaging Biol; 2023 Jun; 25(3):483-494. PubMed ID: 36253663
[TBL] [Abstract][Full Text] [Related]
15. [Relationship between overexpression of facilitative glucose transporter-1 and fluorodeoxyglucose uptake in primary human lung adenocarcinoma].
Wang T; Sun YE; Yao SL; Tian JH; Liu XB; Wang K
Zhonghua Wai Ke Za Zhi; 2004 Aug; 42(16):968-71. PubMed ID: 15363231
[TBL] [Abstract][Full Text] [Related]
16. F-18 FDG uptake on positron emission tomography as a predictor for lymphovascular invasion in patients with lung adenocarcinoma.
Noda Y; Goshima S; Kanematsu M; Watanabe H; Kawada H; Kawai N; Ono H; Bae KT
Ann Nucl Med; 2016 Jan; 30(1):11-7. PubMed ID: 26337532
[TBL] [Abstract][Full Text] [Related]
17. 18F-fluorodeoxyglucose positron emission tomography/computed tomography and the relationship between fluorodeoxyglucose uptake and the expression of hypoxia-inducible factor-1α, glucose transporter-1 and vascular endothelial growth factor in thymic epithelial tumours.
Toba H; Kondo K; Sadohara Y; Otsuka H; Morimoto M; Kajiura K; Nakagawa Y; Yoshida M; Kawakami Y; Takizawa H; Kenzaki K; Sakiyama S; Bando Y; Tangoku A
Eur J Cardiothorac Surg; 2013 Aug; 44(2):e105-12. PubMed ID: 23674658
[TBL] [Abstract][Full Text] [Related]
18. Relationship between 18F-FDG accumulation and lactate dehydrogenase A expression in lung adenocarcinomas.
Zhou X; Chen R; Xie W; Ni Y; Liu J; Huang G
J Nucl Med; 2014 Nov; 55(11):1766-71. PubMed ID: 25342384
[TBL] [Abstract][Full Text] [Related]
19. BATF promotes tumor progression and association with FDG PET-derived parameters in colorectal cancer.
Lu X; Liu J; Feng L; Huang Y; Xu Y; Li C; Wang W; Kan Y; Yang J; Zhang M
J Transl Med; 2024 Jun; 22(1):558. PubMed ID: 38862971
[TBL] [Abstract][Full Text] [Related]
20. Lack of association between KRAS mutations and 18F-FDG PET/CT in Caucasian metastatic colorectal cancer patients.
Krikelis D; Skoura E; Kotoula V; Rondogianni P; Pianou N; Samartzis A; Xanthakis I; Fountzilas G; Datseris IE
Anticancer Res; 2014 May; 34(5):2571-9. PubMed ID: 24778079
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
